Lv22
200 积分 2025-06-25 加入
AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary
9小时前
已完结
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
1天前
已完结
Synthesis and biological evaluation of N-acyl diaryl pyrimidines (NDAPYs) as novel reverse transcriptase inhibitors
16天前
已完结
Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs
16天前
已完结
Where does doravirine fit in current antiretroviral therapy?
16天前
已关闭
No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens
16天前
已完结
Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir‐based dual combinations
16天前
已完结
Predictors for choosing doravirine‐based versus INSTI‐based regimen in ART‐naïve and ART‐experienced people with HIV in real‐world setting: Data from the Icona cohort
16天前
已完结
No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV
16天前
已关闭
Commentary on ‘DORA: 48‐week weight and metabolic changes in black women with HIV, in a phase IIIb switch study from dolutegravir‐ or efavirenz‐ to doravirine‐based first‐line antiretroviral therapy’
16天前
已完结
皖公网安备34019202002308
